SCHEMBL3584460

SCHEMBL3584460

CCOC(=O)C1=C(c2ccccc2)c2c(C)cc(N3CCOCC3)cc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
PPARG P37231 6/20 0.48
ALDH1A1 P00352 6/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
HSP90AA1 P07900 1/20 0.46
MAPK1 P28482 1/20 0.46
MPI P34949 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4657479 0.82 PPARG (0.39) LMNAPPARGALDH1A1HPGDALOX15
SCHEMBL3578416 0.76 LMNA (0.45) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL3565974 0.74 PPARG (0.59) LMNAPPARGALDH1A1HPGDALOX15
SCHEMBL17969781 0.73 ALDH1A1 (0.78) LMNAPPARGALDH1A1HPGDKDM4E
SCHEMBL3572873 0.72 PPARG (0.79) PPARGNPC1RAB9A
SCHEMBL4658819 0.71 PPARG (0.54) LMNAPPARGALDH1A1HPGDALOX15
SCHEMBL7538581 0.71 PPARG (0.72) LMNAPPARGALDH1A1HPGDKDM4E
SCHEMBL8359086 0.70 PPARG (0.63) LMNAPPARGALDH1A1HPGDKDM4E
SCHEMBL3575867 0.69 PPARG (0.63) LMNAPPARGALDH1A1HSD17B10KDM4E
SCHEMBL3576647 0.68 PPARG (0.76) LMNAPPARGALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA LMNA 1791/4885PPARG 8/4885ALDH1A1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.